Literature DB >> 9337021

Evaluation of three different dental implants in ligature-induced peri-implantitis in the beagle dog. Part I. Clinical evaluation.

H W Tillmanns1, J S Hermann, D R Cagna, A V Burgess, R M Meffert.   

Abstract

The purpose of this study was to clinically evaluate experimental peri-implant breakdown. Hydroxyapatite-coated, titanium plasma-sprayed, and machined titanium-alloy surfaces were investigated. Eighty-four implants were placed in 14 beagle dogs. Pocket probing depths and clinical attachment level and mobility measurements were made. Dogs were sacrificed at 3 and 6 months. All experimental implants showed a significant loss in clinical attachment level (P < .05). Increased pocket probing depths for experimental implants occurred during the first 2 months, after which a plateau was reached. At the 3- and 6-month evaluation, pocket probing depths at experimental implants were significantly increased (P < .05). No differences among the three implant types were noted for clinical attachment levels and pocket probing depths. In general, greater mobility was found with the titanium-alloy implants than with hydroxyapatite-coated and titanium plasma-sprayed implants (P < .025). In addition, mobility measurements were significantly greater for experimental titanium-alloy implants during the first 3 months (P < .05). Clinical attachment level measurements were most sensitive to peri-implant status. All implants were equally susceptible to ligature-induced peri-implant breakdown. Consequently, meticulous oral hygiene and regular maintenance care are prerequisites for successful implantology.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9337021

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Implants        ISSN: 0882-2786            Impact factor:   2.804


  1 in total

1.  Bone defect development in experimental canine peri-implantitis models: a systematic review.

Authors:  A Solderer; M de Boer; D B Wiedemeier; M Solderer; C C Liu; P R Schmidlin
Journal:  Syst Rev       Date:  2022-09-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.